Delivery Order SPE2DR25D3102-SPE2DR26F2P3Y
- Not listed
- The Defense Logistics Agency awarded a $13,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. The contract, which is set to be completed by September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded competitively without a set-aside designation, reflecting the contractor's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $19,448.32 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections valued at $10,151.82. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections, with a ceiling value of $10,837.02. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $11,527.36 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 2, 2025, with a completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply requirement for the federal healthcare system. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a $72,385.69 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on December 9, 2025. This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger federal contract vehicle with DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a $6,801.60 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child delivery order under the company's larger indefinite delivery contract vehicle with DLA....
- The Defense Logistics Agency awarded a $18,665.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections on November 4, 2025. This non-set-aside competitive award, with an ultimate completion date of November 5, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P3YDelivery Order
The Defense Logistics Agency awarded a $1,476.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement that extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The firm fixed price structure and competitive award history demonstrate the contractor's established capability to meet federal pharmaceutical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/8/25 |